Money
Filter News
Found 60,722 articles
-
The third time may be the charm for Framingham, Mass.-based Alzheon when it comes to an initial public offering – because the company has balked the first two times it attempted to go public on the stock exchange.
-
U.S. federal lawmakers are discussing various legislative plans that could lower the out-of-pocket expenses many Americans pay for their medications. The plans are coming from both chambers of Congress and with a divided government, lines in the sand will likely be drawn.
-
Acrotech Biopharma, a New Jersey-based subsidiary of Aurobindo Pharma USA, is buying Henderson, Nevada-based Spectrum Pharmaceuticals’ seven FDA-approved hematology/oncology products.
-
HighLife Closes a €32 Million Round B Financing
1/17/2019
HighLife SAS, a medtech company focused on the development of a unique transcatheter mitral valve replacement (“TMVR”) system to treat patients suffering from mitral regurgitation, announced today it had closed a €32 million round of equity financing.
-
Itamar Medical Announces Definitive Agreements for $11.5 Million Private Placement
1/17/2019
Itamar Medical Ltd. (TASE: ITMR), a company that develops, manufactures, and markets non-invasive diagnostic medical devices for sleep apnea with a focus on the cardiology market, today announced that it has entered into definitive agreements for a $11.5 million private placement at a purchase price of NIS 1.1693 per ordinary share of the Company, or $9.55 per American Depositary Share (ADSs), each representing 30 ordinary shares
-
DILIsym Awarded $1.5 Million Phase II NIH Grant
1/17/2019
Phase II Award of NIH Fast Track SBIR Grant for Drug-induced Kidney Injury Software, RENAsym™, Funds Development Over Next 20 Months
-
DionyMed Brands Inc. Signs Definitive Agreement for an up to US$40 Million Credit Facility
1/17/2019
The credit facility consists of a US$15 million term loan facility and a US$25 million asset-backed loan facility.
-
BioIQ White Paper Provides Insights for Employers on Tackling High Cost of Flu
1/17/2019
Paper provides retail and consumer-based strategies to help drive program engagement and ROI
-
Aquinnah Pharmaceuticals Receives $750,000 Grant from the Alzheimer's Association and Tau Consortium to Advance New Therapies for Tauopathy Diseases
1/17/2019
Aquinnah Pharmaceuticals, leaders in stress granule biology that afflict a wide range of neurodegenerative disorders, announced today that it has been awarded $750,000 from the Tau Pipeline Enabling Program (T-PEP) to advance its drug development programs in tauopathy diseases, including Progressive Supranuclear Palsy, Alzheimer's Disease, and Fronto-temporal Dementia.
-
Based in South San Francisco, Five Prime Therapeutics announced that as part of a restructuring program, it will eliminate 41 current jobs, or about 20 percent of its current headcount. The positions cut will be mostly in areas related to research, pathology and manufacturing. The company expects...
-
The notorious legacy of OxyContin continues to be a major black mark against Purdue Pharmaceuticals. And that mark is only getting worse as a court case against the opioid manufacturer has revealed company officials used deceptive marketing practices to boost sales of the drug.
-
On Jan. 11, President Donald Trump announced via Twitter that 2018 was marked by a decline in prescription drug prices – the first time that had happened in 50 years. Also, the president said that Americans saved $26 billion on drug prices in the first 19 months of his presidency.
-
In 2018 alone, mergers and acquisitions (M&A) activity among the life sciences industry totaled US$198B according to the 2019 EY M&A Firepower Report. The report continues on to state that "Life sciences M&A in 2018 was strong but failed to meet market expectations as companies focused on portfol...
-
Preference for Portable ENT Diagnostic Devices Surging Among End-Users
1/16/2019
ENT diagnostic devices market is estimated to hit US$ 2.3 billion in 2019, according to a new study by Fact.MR. The market grew at 6.3% y-o-y in 2018 with bronchoscopes accounting for nearly one third of the global revenues.
-
TRX® Completes Strategic Growth Recapitalization
1/16/2019
Founder Partners with Industry-Focused Private Equity Firm to Power Next Chapter of TRX's Ongoing Mission as the Global Leader in Functional Training Solutions & Programming
-
ADURO Secures $22 Million From Abry Partners to Radically Shift the Health & Well-being Sector
1/16/2019
Top Private Equity Investor Fuels Human Performance Company to Elevate Organizations and Their Employees to Be Great at Anything
-
Tyto Care Extends Series C Funding to Add Key Strategic Partnerships, Bringing Total Funds Raised to $33.5M
1/16/2019
Tyto Care, an innovative telehealth company enabling live telehealth visits and comprehensive medical examinations, today announced that it has closed $9M in additional funding from strategic investors including Sanford Health, Itochu and Shenzhen Capital Group (and its affiliates).
-
Alpine Immune Sciences Announces $25 Million Private Placement
1/16/2019
Alpine Immune Sciences, Inc. today announced it has entered into a definitive securities purchase agreement for the sale of units consisting of shares of common stock and warrants to purchase common stock
-
JustRight Surgical, Now Bolder Surgical, Secures $27 Million in Growth Capital
1/16/2019
JustRight Surgical, LLC, now Bolder Surgical, today announced it has secured $27 million in financing led by River Cities Capital Funds with participation from Westwood Management, Providence Ventures and previous investors.
-
CRG Commits $70 Million to Mid-Atlantic Dental Partners
1/16/2019
CRG announced a $70 million commitment to Mid-Atlantic Dental Partners, a dental support organization dedicated to improving the delivery of dental services for patients in several markets across the country and a portfolio company of S.C. Goldman & Company, LLC ("S.C. Goldman").